To Increase Patient Access

Post Archives

February 15, 2024
Access All of Your Medical Records with xCures

xCures can work with your doctor to help you access new treatments by providing access to your electronic medical records.

Read More
February 8, 2024
Clinical Trial for Patients with Primary Central Nervous System Lymphoma (PCNSL)

Ono Pharma is actively recruiting patients with Primary Central Nervous System Lymphoma (PCNSL) for the PROSPECT Study, which is evaluating an oral medicine called Tirabrutinib.

Read More
January 29, 2024
Revolutionizing Cancer Care: Advances in Radiation Therapy for Brain Tumors

Modern radiation therapy for brain tumors, marked by precision, personalization, safety, and ongoing innovation, holds promise for enhancing patient outcomes and instilling hope in challenging diagnoses.

Read More
January 29, 2024
EBCI Expands Access to Pediatric Treatments

Sasha Quijano-Edwards, in her new role as Pediatric Clinical Trial Coordinator & Patient Navigator, Sasha hopes to provide much needed support to patients and families.

Read More
January 23, 2024
Clinical Study for Patients with Newly Diagnosed Metastatic Brain Tumors

The Roads Clinical Study is designed for patients diagnosed with a metastatic brain tumor.

Read More
January 18, 2024
Patients Need YOUR Help to Access Treatments: Support The Promising Pathway Act

The Promising Pathway Act will have a massive positive impact on treatments for GBM. Contact your senators and representatives today to ask for their support.

Read More
January 9, 2024
ONLY FOUR SPOTS LEFT! Opportunity for Patients Living with rGBM

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
December 29, 2023
LAST CHANCE to Double Your Donation! 

All donations made before December 31st will be matched dollar for dollar, up to $25,000! 

Read More
December 28, 2023
Happy Holidays from the End Brain Cancer Initiative!

The End Brain Cancer Initiative wishes you a very happy holiday season and a wonderful new year!

Read More
December 23, 2023
Important Updates to EBCI's Hours

Announcement of EBCI's hours of operation and extended hours for the clinical research coordinator.

Read More
December 21, 2023

A generous supporter of the End Brain Cancer Initiative has pledged to match all donations made before December 31st dollar for dollar, up to $25,000.

Read More
December 19, 2023
Help Patients Access Treatments By Showing Your Support For The Promising Pathway Act

The Promising Pathway Act shortens the approval process for revolutionary treatments, helping the people access these promising new treatments.

Read More
1 2 3 17


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram